Trial reportJournal of neurology2016
Brief intervention by general practitioners for medication-overuse headache, follow-up after 6 months: a pragmatic cluster-randomised controlled trial.
Trial report in Journal of neurology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
RCT of Structured Brief Intervention for Medication Overuse Headache Versus Business as Usual
Brief Intervention for Reducing Prolonged Use of Sleep Medication Among Elderly
Who cites it
20 citing papers in PubMed, 41 citations in OpenAlex.
- FRAMES protocol versus simple advice for medication-overuse headache: a prospective, randomized, controlled clinical trial.Acta neurologica Belgica · 2021Trial
- Comparison of 3 Treatment Strategies for Medication Overuse Headache: A Randomized Clinical Trial.JAMA neurology · 2020Trial
- Trial
- Headache patients' satisfaction with telemedicine: a 12-month follow-up randomized non-inferiority trial.European journal of neurology · 2017Trial
- An exploration of possible future non-pharmacological multidisciplinary treatments to potentiate withdrawal strategy and recovery from medication overuse headache (MOH): a narrative review.Journal of oral & facial pain and headache · 2026Review
- The Nursing Role in the Management of Medication Overuse Headache: Realities and Prospects.Brain sciences · 2024Review
- Delayed opportunities for patient-provider communication about medication overuse headache: Mixed methods perspectives from patients and neurologists.Preventive medicine reports · 2024Article
- Brief Intervention as a Method to Reduce Z-Hypnotic Use by Older Adults: Feasibility Case Series.JMIR formative research · 2024Article
- Association between awareness and knowledge of medication-overuse headache with medication-taking behavior among adults with migraine.PloS one · 2024Article
- Rethinking headache as a global public health case model for reaching the SDG 3 HEALTH by 2030.The journal of headache and pain · 2023Review
- A Descriptive Review of Medication-Overuse Headache: From Pathophysiology to the Comorbidities.Brain sciences · 2023Review
- Diagnosis and management of migraine in ten steps.Nature reviews. Neurology · 2021Review
- Article
- Chronic migraine: Genetics or environment?European journal of neurology · 2021Article
- Epidemiology and management of medication-overuse headache in the general population.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2019Review
- Brain Structural and Functional Imaging Findings in Medication-Overuse Headache.Frontiers in neurology · 2019Review
- Medication-overuse headache: a widely recognized entity amidst ongoing debate.The journal of headache and pain · 2018Review
- Article
- Effect of Educating the Primary Care Physician About Headache to Help Reduce "Trivial" Referrals and Improve the Number and Quality of "Substantial" Referrals that Truly Need Subspecialty Headache Medicine Care.Current treatment options in neurology · 2017Review
- Nucleus accumbens functional connectivity discriminates medication-overuse headache.NeuroImage. Clinical · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
unlabelledMedication-overuse headache (MOH) is a common health problem. Withdrawal of the overused medication is the treatment of choice. We investigated the long-term effectiveness of brief intervention (BI) for MOH patients in primary care. The BI for MOH in primary care study was a blinded, pragmatic, cluster-randomised controlled trial. 25,486 patients (age 18-50) from 50 general practitioners (GPs) were screened for MOH. GPs defined clusters and 23 GPs were randomised to receive BI training and 27 GPs to continue business as usual (BAU). The GPs assessed their MOH patients with the Severity of Dependence Scale, gave individual feedback about the risk of MOH and advice to reduce headache medication. Primary outcomes, assessed 6 months after the intervention, were reduction in headache and medication days/month. 42% were screening responders. 2.4% had self-reported MOH. A random selection of 104 patients with self-reported MOH were invited, 75 were randomised out of which 60 with a physician-defined MOH diagnosis were included. None were lost to follow-up. BI was significantly better than BAU regarding primary outcomes (p < 0.001-0.018). Headache and medication days were reduced by 5.9 (95% CI 1.1-10.8) and 6.2 (1.1-11.3) more days/month in BI than BAU group. Chronic headache resolved in 63 and 11% in the BI and the BAU group (p < 0.001). Headache-related disability was lower among those who detoxified. In conclusion, BI is an effective treatment in primary care with lasting effect 6 months after the intervention for MOH.
trial registrationClinicalTrials.gov identifier: NCT01314768.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.